Appeal No. 95-2244
Application 08/036,648
a drug to a fluid environment of use, wherein the
dosage form comprises:
(a) a drug composition comprising a
dose of 0.05 ng to 1.5 g of a calcium channel
blocker drug, and a polymer comprising a molecular
weight up to 1,000,000 and a rate of hydration in
the presence of fluid that contacts the dosage form
to change from a non-dispensable phase to a
dispensable phase; and,
3
Page: Previous 1 2 3 4 5 6 7 8 9 10 11 12 Next
Last modified: November 3, 2007